cGMP Manufacturing
Product Description
COBRA BIOLOGICS
-
GB
-
2015On CPHI since
Categories
Specifications
COBRA BIOLOGICS
-
GB
-
2015On CPHI since
More Products from COBRA BIOLOGICS (2)
-
Product Aseptic Pharmaceuticals Manufacture
Our comprehensive service offering includes the capability for producing sterile drug products, utilising full disposable systems and meeting rigorous sterility requirements in accordance with aseptic manufacturing procedures.
With batch sizes from 1 to 100 litres, Cobra can manufacture ... -
Product Viral Vector Development
Cobra is an experienced manufacturer of cGMP viral vector products for gene therapies and vaccines offering - Platform Process Development and Scale Up - GMP Cell Banking & Viral Seed Stocks- GMP Manufacture- Viral Vector Analytical Development & Qualification- Stability Studies
COBRA BIOLOGICS resources (3)
-
News Cobra Biologics to manufacture plasmids for COVID-19 vaccine trial
Scancell’s DNA vaccine could provide long-lasting immunity against COVID-19 by generating protection against this and new strains of coronavirus. -
News Cobra Biologics completes production of master cell banks for epilepsy gene therapy drug candidate
This milestone secures future production of CombiGene's CG01 drug candidate to treat drug-resistant focal epilepsy. -
News Cobra Biologics delivers final plasmids for CombiGene's epilepsy project
Further milestone paves the way for production of novel gene therapy drug candidate designed to treat drug-resistant focal epilepsy.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance